Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125282652 | 12528265 | 2 | F | 201112 | 20160629 | 20160705 | 20160708 | EXP | US-PFIZER INC-2016324919 | PFIZER | 65.00 | YR | F | Y | 61.23000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125282652 | 12528265 | 1 | PS | DILANTIN | PHENYTOIN | 1 | U | 10151 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125282652 | 12528265 | 1 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125282652 | 12528265 | OT |
| 125282652 | 12528265 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125282652 | 12528265 | Blindness transient | |
| 125282652 | 12528265 | Drug ineffective | |
| 125282652 | 12528265 | Eye haemorrhage | |
| 125282652 | 12528265 | Fall | |
| 125282652 | 12528265 | Head injury | |
| 125282652 | 12528265 | Hip fracture | |
| 125282652 | 12528265 | Malabsorption | |
| 125282652 | 12528265 | Neovascular age-related macular degeneration | |
| 125282652 | 12528265 | Peripheral swelling | |
| 125282652 | 12528265 | Thyroid function test abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |